GE HealthCare Technologies Inc.

For the period ended Jun 30, 2026. Filed Jul 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 29, 2026

GEHC$83.65-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

Condensed Consolidated Statements of Income (Unaudited)
	For the three months ended June 30		For the six months ended June 30
(In millions, except per share amounts)	2026	2025	2026	2025
Sales of products	$3,416	$3,263	$6,762	$6,380
Sales of services	1,878	1,743	3,664	3,404
Total revenues	5,295	5,007	10,425	9,784
Cost of products	2,217	2,160	4,500	4,122
Cost of services	898	863	1,769	1,665
Gross profit	2,180	1,985	4,157	3,997
Selling, general, and administrative	1,118	1,029	2,235	2,069
Research and development	323	302	668	646
Total operating expenses	1,441	1,331	2,903	2,714
Operating income	739	654	1,254	1,283
Interest and other financial charges – net	114	113	210	224
Non-operating benefit (income) costs	(45)	(73)	(96)	(148)
Other (income) expense – net	(22)	1	(58)	(98)
Income before income taxes	693	613	1,198	1,304
Benefit (provision) for income taxes	(119)	(113)	(213)	(216)
Net income	573	500	985	1,088
Net (income) loss attributable to noncontrolling interests	(13)	(14)	(35)	(39)
Net income attributable to GE HealthCare	$561	$486	$950	$1,049
Earnings per share attributable to GE HealthCare:
Basic	$1.24	$1.06	$2.09	$2.30
Diluted	1.24	1.06	2.08	2.29
Weighted-average number of shares outstanding:
Basic	453	457	454	457
Diluted	454	458	456	459

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.